No Level 4 Travel Health Notices currently exist according to CDC data, as no disease outbreak meets the agency's criteria of extreme traveler risk with no effective precautions available. Recent surveillance through early June 2026 shows only lower-level alerts, including a May Level 3 notice for Ebola in the Democratic Republic of the Congo and scattered Level 2 advisories for malaria and other vector-borne illnesses, with case trends remaining geographically contained and stable under official monitoring. Dengue and polio updates from March and May stayed at Level 1 or 2 despite global activity. Market-implied odds of 77% for no issuance by year-end reflect trader assessment that current epidemiological indicators and CDC thresholds make an extreme escalation unlikely absent a rapid, unprecedented shift in transmission dynamics before December.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertCDC gibt Warnung der Stufe 4 bis zum 31. Dezember aus?
Ja
$71,848 Vol.
$71,848 Vol.
Ja
$71,848 Vol.
$71,848 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Markt eröffnet: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...No Level 4 Travel Health Notices currently exist according to CDC data, as no disease outbreak meets the agency's criteria of extreme traveler risk with no effective precautions available. Recent surveillance through early June 2026 shows only lower-level alerts, including a May Level 3 notice for Ebola in the Democratic Republic of the Congo and scattered Level 2 advisories for malaria and other vector-borne illnesses, with case trends remaining geographically contained and stable under official monitoring. Dengue and polio updates from March and May stayed at Level 1 or 2 despite global activity. Market-implied odds of 77% for no issuance by year-end reflect trader assessment that current epidemiological indicators and CDC thresholds make an extreme escalation unlikely absent a rapid, unprecedented shift in transmission dynamics before December.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen